Compare

Aevis Victoria SA/Fr. AEVS

1D1W1M3M6MYTD1Y5YMAX

About Aevis Victoria SA

Aevis Victoria SA operates in the healthcare and hospitality sectors, primarily focused on the management of private clinics and luxury hotels. The company owns and manages a network of Swiss private clinics through its subsidiary, Swiss Medical Network, providing a range of medical services. In the hospitality segment, Aevis Victoria has investments in several luxury hotels under its subsidiary, Victoria-Jungfrau Collection, offering upscale accommodation and services in Switzerland. Headquartered in Fribourg, Switzerland, the company benefits from its strategic positioning in high-demand markets, leveraging its expertise to integrate healthcare services with hospitality. Its diverse portfolio across healthcare and luxury accommodations forms the basis of its business model.
Ticker
Fr. AEVS
Sector
Health
Primary listing
XSWX
Employees
4,870
Headquarters
Fribourg, Switzerland
Website
www.aevis.com

AEVS Metrics

BasicAdvanced
CHF 1.2B
-
-CHF 0.23
-0.09
-

What the Analysts think about AEVS

Analyst ratings (Buy, Hold, Sell) for Aevis Victoria SA stock.
Analyst projections of the future price of Aevis Victoria SA stock.

Bulls say / Bears say

Swiss Medical Network is converting cost control and operating improvements into faster profit growth: nine-month EBITDA rose 41% and EBITDAR rose 17.3%, while the EBITDAR margin expanded to 18.3%. This is a stronger earnings trend than the modest increase in underlying revenue alone suggests. (EQS News)
Swiss Medical Network extended its CHF 150 million bank facility to April 2028, with an option for another year, and secured a 100-basis-point reduction in its financing margin. The company linked the lower rate to improved profitability and reduced net debt, easing near-term refinancing pressure and interest costs. (EQS News)
The hotel portfolio is lifting room yields without relying on higher occupancy: nine-month average room rates rose 5.4% and revenue per available room increased 5.1%, while occupancy held at 57.4%. September revenue accelerated by 9.2% year on year. (EQS News)
The healthcare business is still growing slowly beneath the headline figures: nine-month net revenue rose only 1.2%, or 0.5% on a constant-scope basis, while hospital net revenue fell 0.5%. Much of the reported gross-revenue increase reflects a change in how independent doctors’ fees are presented, rather than stronger underlying activity. (EQS News)
AEVIS said it will not pay a dividend in 2026. Management cited the need to review financing after Credit Suisse’s disappearance and restrictions affecting some business segments, limiting near-term cash returns to shareholders. (Allnews)
The shares still trade at a reported discount of more than 50% to net asset value, leaving investors exposed to the risk that the gap persists. Management identified future stake sales to strategic investors as a possible catalyst, but those plans still need to translate into completed transactions. (StockAnalysis)
Data summarised monthly by Lightyear AI. Last updated on 10 Nov 2026.

AEVS Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

AEVS Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.